Susquehanna International Group
PGNX

Susquehanna International Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Susquehanna International Group’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-43,700
Closed -$166K – 11410
2020
Q1 		$166K Buy
43,700
+600
+1% +$2.58K ﹤0.01% 8900
2019
Q4 		$219K Sell
43,100
-13,300
-24% -$70.4K ﹤0.01% 8612
2019
Q3 		$285K Buy
56,400
+24,600
+77% +$123K ﹤0.01% 8400
2019
Q2 		$196K Buy
+31,800
New +$153K ﹤0.01% 9141
2019
Q1 		– Sell
-10,800
Closed -$45K – 10320
2018
Q4 		$45K Sell
10,800
-35,700
-77% -$182K ﹤0.01% 8520
2018
Q3 		$292K Sell
46,500
-283,600
-86% -$2.18M ﹤0.01% 7541
2018
Q2 		$2.65M Sell
330,100
-380,100
-54% -$2.9M ﹤0.01% 3577
2018
Q1 		$5.3M Buy
710,200
+697,700
+5,582% +$4.64M ﹤0.01% 2474
2017
Q4 		$74K Sell
12,500
-13,800
-52% -$83.8K ﹤0.01% 8805
2017
Q3 		$194K Sell
26,300
-3,400
-11% -$21.6K ﹤0.01% 8039
2017
Q2 		$202K Sell
29,700
-33,500
-53% -$247K ﹤0.01% 8273
2017
Q1 		$597K Sell
63,200
-22,200
-26% -$222K ﹤0.01% 6167
2016
Q4 		$738K Buy
85,400
+51,300
+150% +$379K ﹤0.01% 6164
2016
Q3 		$216K Buy
34,100
+9,000
+36% +$54.4K ﹤0.01% 7466
2016
Q2 		$106K Sell
25,100
-17,400
-41% -$84K ﹤0.01% 7996
2016
Q1 		$185K Sell
42,500
-9,300
-18% -$41.4K ﹤0.01% 8033
2015
Q4 		$318K Buy
51,800
+39,900
+335% +$262K ﹤0.01% 7579
2015
Q3 		$68K Sell
11,900
-7,800
-40% -$59.9K ﹤0.01% 9290
2015
Q2 		$147K Sell
19,700
-26,900
-58% -$163K ﹤0.01% 9498
2015
Q1 		$279K Sell
46,600
-16,200
-26% -$102K ﹤0.01% 8105
2014
Q4 		$475K Sell
62,800
-148,800
-70% -$890K ﹤0.01% 7305
2014
Q3 		$1.1M Buy
211,600
+180,700
+585% +$901K ﹤0.01% 5753
2014
Q2 		$133K Sell
30,900
-56,100
-64% -$214K ﹤0.01% 9307
2014
Q1 		$356K Buy
87,000
+35,800
+70% +$183K ﹤0.01% 7318
2013
Q4 		$273K Buy
51,200
+35,300
+222% +$155K ﹤0.01% 7742
2013
Q3 		$80K Buy
+15,900
New +$86.3K ﹤0.01% 8147

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Susquehanna International Group's PGNX Position: Q2 2020 in Review

Susquehanna International Group sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 65,909 shares — an estimated $250K sold.

Susquehanna International Group first reported a position in PGNX in Q3 2013 and held it in 24 quarters. The position peaked at $2.89M in Q1 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Susquehanna International Group reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Susquehanna International Group sold 65,909 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $250K.
  • Susquehanna International Group first reported a position in Progenics Pharmaceuticals Inc in Q3 2013 and held it in 24 quarters.
  • Susquehanna International Group's Progenics Pharmaceuticals Inc position peaked at $2.89M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.